Astellas Pharma : Announces Personnel Changes and Organizational Changes (pdf 57KB)

Microsoft Word - 160208_HR_Eg_FINAL.docx

Astellas Announces Personnel Changes and Organizational Changes

Tokyo, February 8, 2016 - Astellas Pharma Inc. (President and CEO: Yoshihiko Hatanaka) today announced the personnel changes and organizational changes as below.

1. Appointment of Senior Corporate Executive effective on April 1, 2016

   
   

   Name	New Title	Current Title
   Masao Yoshida	CEO's Office	President, Americas Operations

   
   

2. Appointments of Corporate Executive effective on April 1, 2016

Name	New Title	Current Title
Shouji Yokota	CEO's Office	Divisional Senior Vice President, Technology Product Management, Technology
Takahisa Iizuka	CEO's Office	Divisional Senior Vice President, Sales Operation, Japan Sales & Marketing
Chihiro Yokota	Head of Japan/Asia Development, Development	Head of Japan/Asia Development, Development and Head of Medical Affairs, Japan
Atsushi Kamide	Vice President, Healthcare Policy & CSR	Divisional Senior Vice President, Product Marketing, Japan Sales & Marketing
Kiyotaka Hayashi	Divisional Senior Vice President, Sales Operation, Japan Sales & Marketing	General Manager, Osaka Branch, Japan Sales & Marketing
Chikashi Takeda	Corporate Vice President, Corporate Finance & Control	Corporate Vice President, Corporate Planning

Name	Title (effective on April 1, 2016)
Masao Yoshida	CEO's Office

1. Resignations of Corporate Executive effective on June 20, 2016

   
   

   Name	Title (effective on April 1, 2016)
   Shouji Yokota	CEO's Office
   Takahisa Iizuka	CEO's Office

   
   

2. New Corporate Executives effective on June 20, 2016

   
   

   Name	Title (effective on April 1, 2016)
   Naoki Okamura	Corporate Vice President, Corporate Planning
   Takuya Oshida	Senior Vice President, Head of Medical Affairs, Japan
   Yasuhiro Kanzaki	General Manager, Osaka Branch, Japan Sales & Marketing

   
   

3. Personnel Changes effective on April 1, 2016

Name	New Title	Current Title
James Robinson	President, Americas Operations	President, Astellas Pharma US, Inc.
Kunihiko Kokubo	Head of Quality Assurance	Vice President, Quality Assurance, Japan, Asia & Oceania
Takuya Oshida	Head of Medical Affairs, Japan	Vice President, Medical Science, Medical Affairs, Japan
Naoki Okamura	Corporate Vice President, Corporate Planning	Corporate Vice President, Business Development
Jun Kono	Corporate Vice President, Business Development	Vice President, Corporate Strategy & Communications, EMEA*
Koichiro Morihira	Vice President, Intellectual Property	Executive Director, Intellectual Property
Motoi Aoki	Vice President, Quality Assurance, Japan, Asia & Oceania	Senior Director, Quality Assurance, EMEA*
Aiji Miyashita	Vice President, Clinical and Research Quality Assurance	Senior Director, Analysis & Pharmacokinetics Research Labs., Drug Discovery Research

Akira Unami	Vice President, Drug Safety Research Labs., Drug Discovery Research	Senior Director, Drug Safety Research Labs., Drug Discovery Research
Hideki Maeda	Vice President, Medical Science, Medical Affairs, Japan	Vice President, Medical Research, Medical Affairs, Japan
Yasushi Ikeda	Vice President, Medical Research, Medical Affairs, Japan	Senior Director, Medical Science, Medical Affairs, Japan
Naoko Sato	Vice President, Medical Communications, Japan, Medical Affairs, Japan	Vice President, Medical Information Center, Medical Affairs, Japan
Katsutoshi Nakamura	Vice President, Technology Product Management, Technology	Executive Director, Technology Product Management, Technology
Shigeru Ieda	Vice President, Process Chemistry Labs., Technology	General Manager, Astellas Pharma Tech Co., Ltd.
Shiro Yamamoto	Divisional Senior Vice President, Product Marketing, Japan Sales & Marketing	Executive Director, Product Marketing, Japan Sales & Marketing
Akihiro Takimoto	Vice President, Distribution Relations, Japan Sales & Marketing	Senior Director, Distribution Relations, Japan Sales & Marketing
Norihito Matsunami	General Manager, Sapporo Branch, Japan Sales & Marketing	Senior Director, Nagoya Branch, Japan Sales & Marketing
Masayuki Ohki	General Manager, Kanetsu Branch, Japan Sales & Marketing	General Manager, Yokohama Branch, Japan Sales & Marketing
Sakakiya Hiroshi	General Manager, Yokohama Branch, Japan Sales & Marketing	Executive Director, Kobe Branch, Japan Sales & Marketing
Yasuhiro Kanzaki	General Manager, Osaka Branch, Japan Sales & Marketing	General Manager, Sapporo Branch, Japan Sales & Marketing

* EMEA: Europe, Middle East and Africa

Name	New Title	Current Title
Akira Sekine	President, Astellas Learning Institute Co., Ltd.	Executive Director, Human Resources Astellas Pharma Inc.
Ryoichi Uematsu	President, Astellas Analytical Science Laboratories, Inc.	Senior Director, Technology Planning & Administration, Technology Astellas Pharma Inc.

1. Appointment of Staff Executive Director effective on April 1, 2016

   
   

   Name	New Title	Current Title
   Mineo Takahashi	Staff Executive Director, Japan Sales & Marketing	Vice President, Distribution Relations, Japan Sales & Marketing

   
   

2. Organizational Changes effective on April 1, 2016

Healthcare Policy & CSR

A corporate division, Healthcare Policy & CSR, will be newly established by consolidating functions responsible for taking actions to improve patient access to health care. Vice President of Healthcare Policy & CSR will report to Chief Strategy Officer.

Medical Information Center

The name of Medical Information Center will be changed to Medical Communications, Japan.

About Astellas

Astellas Pharma Inc., based in Tokyo, Japan, is a company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. We focus on Urology, Oncology, Immunology, Nephrology and Neuroscience as prioritized therapeutic areas while advancing new therapeutic areas and discovery research leveraging new technologies/modalities. We are also creating new value by combining internal capabilities and external expertise in the medical/healthcare business. Astellas is on the forefront of healthcare change to turn innovative science into value for patients. For more information, please visit our website at www.astellas.com/en.